Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 219-110-7 | CAS number: 2362-14-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 001
- Report date:
- 2001
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.2600 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- Buehler test
- Justification for non-LLNA method:
- Study conducted prior to adoption of LLNA guideline by the OECD.
Test material
- Reference substance name:
- 4,4'-cyclohexylidenedi-o-cresol
- EC Number:
- 219-110-7
- EC Name:
- 4,4'-cyclohexylidenedi-o-cresol
- Cas Number:
- 2362-14-3
- Molecular formula:
- C20-H24-O2
- IUPAC Name:
- 4-[1-(4-hydroxy-3-methylphenyl)cyclohexyl]-2-methylphenol
- Test material form:
- solid: particulate/powder
- Details on test material:
- - Name of test material (as cited in study report): Dimethyl cyclohexyl bisphenol (DMBPC; CAS No. 2362-14-3)
- Synonyms: Dimethyl bisphenolcyclohexane; 4,4’-cyclohexylidene di-o-cresol; 1,1-Bis(4-hydroxy-3-ethyl)cyclohexane; Bis-OC-Z
- Appearance: fine white powder
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Hartley
- Sex:
- male/female
- Details on test animals and environmental conditions:
- Nineteen male and 19 female (nulliparous and non-pregnant) Hartley guinea pigs were received from the supplier. They weighed 380.9 to 427.2 g and were at least 21 days old. They were group-housed upon arrival in stainless steel suspended cages. The animals were acclimated for at least 5 days prior to dosing. Water and feed were provided ad libitum. The temperature and humidity were maintained at 68 ± 5 °F and 30 - 70 %, respectively. Room lights were on a 12-hour light/dark cycle.
Study design: in vivo (non-LLNA)
Induction
- Route:
- epicutaneous, occlusive
- Vehicle:
- unchanged (no vehicle)
- Concentration / amount:
- 100 % for induction doses
Challenge
- Route:
- epicutaneous, occlusive
- Vehicle:
- unchanged (no vehicle)
- Concentration / amount:
- 100 % for challenge doses
- No. of animals per dose:
- 10 males/10 females Test group (100 % DMBPC topical)
5 males/5 females Negative control group
3 males/2 females Positive control group
1 male/2 females for the preliminary irritation test - Details on study design:
- A preliminary irritation test was conducted, in which DMBPC, at concentrations of 100 % (neat) and 50, 25 and 10 % in 80 % ethanol was applied to the skin of 3 guinea pigs for 6 hours. The response was scored 24 hours after the test substance application and the test substance was determined not to be an irritant. Therefore, DMBPC at a concentration of 100 % (neat) was chosen for the topical induction and challenge doses.
For the main test, the application sites were prepared by clipping and shaving or depilating the skin of the scapular region in an area of about 3 x 4 cm. Animals were weighed on Day 0 (before induction application) and again at the end of the test (Day 30) and any clinical observations were recorded.
For the induction, on Days 0, 7 and 14, closed patches were prepared with the test substance and applied directly to the skin on one side of the animal and covered with a gauze pad of approximately 4-6 cm². The test substance was used at 100 % since the preliminary irritation screen indicated that it was not an irritant. The patch was kept in place with occlusive bandaging. After 6 hours the patch was removed and any residual test substance was wiped off with a gauze pad.
During induction, the positive control substance (0.4 mL of 0.1 % DNCB in acetone) was applied in the same manner. Naïve animals (i.e. untreated during the induction phase) served as a negative control group.
For the challenge, a 4 x 3 cm virgin skin site was shaved on the flanks of the experimental and control animals. The challenge test was performed on the freshly clipped skin sites of the test and naïve control animals in the same manner as the 6-hour closed patch test of the induction phase. The skin was exposed to the test substance at 100 % (the highest non-irritating concentration determined in the preliminary irritation study) for 6 hours.
The experimental and negative control animals were exposed to one dose of test substance on week 05; 0.1 % Dinitrochlorobenzene (DNCB) in acetone was used to challenge the positive control animals.
At approximately 21 hours after removal of the challenge dose, the area of the challenge was marked and the entire back was shaved. Approximately three hours after shaving, the test site was examined for erythema and oedema. The reaction was graded according to the following Magnusson and Kligman Grading Scale for the Evaluation of Challenge Patch Test reactions.
0 = No visible change
1 = Discrete or patchy erythema
2 = Moderate and confluent erythema
3 = Intense erythema and swelling
Evaluation of the challenge area was repeated at approximately 48 hours after removal of the challenge dose patch and the skin reactions were graded.
The results are summarised and expressed in the following terms:
- Incidence: The number of animals showing a response of 1 or more at 24 and 48 hours divided by the number of animals tested; expressed as a percentage.
- Severity: The sum of the test grades divided by the number of animals tested.
At the end of the study, all animals were weighed, then sacrificed by CO2 inhalation. - Challenge controls:
- 5 males/5 females Negative control group
- Positive control substance(s):
- yes
- Remarks:
- 0.1% DNCB in acetone
Results and discussion
- Positive control results:
- A sensitization response was observed in all positive control animals confirming the validity of the test method.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 100 %. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 100 %. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: none.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 100 %. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: none.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 100 %
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 100 %. No with. + reactions: 0.0. Total no. in groups: 20.0. Clinical observations: none.
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 0.1 %
- No. with + reactions:
- 5
- Total no. in group:
- 5
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: positive control. Dose level: 0.1 %. No with. + reactions: 5.0. Total no. in groups: 5.0. Clinical observations: none.
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 0.1 %
- No. with + reactions:
- 5
- Total no. in group:
- 5
- Clinical observations:
- none
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: positive control. Dose level: 0.1 %. No with. + reactions: 5.0. Total no. in groups: 5.0. Clinical observations: none.
Any other information on results incl. tables
- Preliminary Irritation Trial: Irritation (erythema or oedema) was not observed on any test site at test article concentrations as high as 100 % at the 24 hour observation period.
- Induction and Challenge Phases: All animals gained weight during the course of the study and no abnormal clinical observations were noted. No test animals showed signs of erythema or oedema at the 24 and 48 hour observations points for the challenge phase. No reactions were observed in the negative control group and 100 % reactivity was observed in the positive control group at challenge. The incidence and severity of the responses post-challenge were calculated as shown below.
Results
| Negative Control | Test | Positive Control | |||
| 24 hours | 48 hours | 24 hours | 48 hours | 24 hours | 48 hours |
Incidence* | 0/10 = 0% | 0/10 = 0% | 0/20 = 0% | 0/20 = 0% | 5/5 = 100% | 5/5 = 100% |
Severity** | 0/10 = 0 | 0/10 = 0 | 0/20 = 0 | 0/20 = 0 | 13/5 = 2.6 | 11/5 = 2.2 |
*Incidence – The number of animals showing a response of 1 or more divided by the number of animals tested; expressed as a percentage.
**Severity – The sum of the test reaction grades divided by the number of animals tested.
Remarks on results: All animals gained weight over the course of the study. No systemic signs of toxicity were observed in any animal over the course of the study. None of the test animals exhibited any signs of erythema at any of the observation points. None of the negative control animals exhibited erythema at either the 24- or 48-hour observation periods following challenge application.
Applicant's summary and conclusion
- Interpretation of results:
- other: Not classified according to EU criteria
- Conclusions:
- Under the conditions of this study, DMBPC was not considered to be a skin sensitiser.
- Executive summary:
The potential of the test material to cause skin sensitisation was investigated in a Buehler test conducted in accordance with the standardised guidelines OECD 406 and EPA OPPTS 870.2600 under GLP conditions.
Male and female Hartley guinea pigs were exposed to the neat test material during both the challenge and induction phases following a preliminary test.
For the induction, on Days 0, 7 and 14, closed patches were prepared with the test substance and applied directly to the skin .The patch was kept in place with occlusive bandaging; after 6 hours the patch was removed and any residual test substance was wiped off with a gauze pad. The positive control substance (0.4 mL of 0.1 % DNCB in acetone) was applied in the same manner. Naïve animals (i.e. untreated during the induction phase) served as a negative control group.
The challenge test was performed on the freshly clipped skin sites of the test and naïve control animals in the same manner as the 6-hour closed patch test of the induction phase. The skin was exposed to the test substance at 100 % for 6 hours. The experimental and negative control animals were exposed to one dose of test substance on week 05; 0.1 % Dinitrochlorobenzene (DNCB) in acetone was used to challenge the positive control animals.
At approximately 24 hours after removal of the challenge dose, the test site was examined for erythema and oedema. Evaluation of the challenge area was repeated at approximately 48 hours after removal of the challenge dose patch and the skin reactions were graded.
No test animals showed signs of erythema or oedema at the 24 and 48 hour observations points for the challenge phase. No reactions were observed in the negative control group and 100 % reactivity was observed in the positive control group at challenge. All animals gained weight during the course of the study and no abnormal clinical observations were noted.
Under the conditions of this study, DMBPC was not considered to be a skin sensitiser.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.